Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$14.89 0.21 (1.43%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.54(B)
Last Volume: 772,336 Avg Vol: 1,689,102
52 Week Range: $11.5 - $17.51
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 50,000 304,000 330,151 4,223,516
Total Sell Value $803,000 $4,338,050 $4,684,028 $62,649,148
Total People Sold 2 6 7 12
Total Sell Transactions 2 8 9 53
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 312
  Page 10 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ingenito Gary Chief Medical Officer   •       –      –    2019-12-04 4 OE $2.53 $379,500 D/D 150,000 150,000     -
   Ingenito Gary Chief Medical Officer   •       –      –    2019-11-21 4 S $4.50 $449,800 D/D (100,000) 0     -
   Ingenito Gary Chief Medical Officer   •       –      –    2019-11-20 4 OE $0.79 $79,000 D/D 100,000 100,000     -
   O'keeffe Charles B Director   –       •      –    2019-10-11 4 B $4.70 $46,950 D/D 10,000 553,376 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2019-10-03 4 B $4.89 $48,900 D/D 10,000 4,772,693 2.81     -
   Mcenany Patrick J President and CEO   •       •      –    2019-06-11 4 B $3.23 $80,750 D/D 25,000 4,762,693 2.81     -
   Denkhaus Donald A Director   –       •      –    2018-12-27 4 B $1.91 $47,750 D/D 25,000 225,000 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2018-12-19 4 B $2.24 $44,800 D/D 20,000 4,737,693 2.81     -
   Denkhaus Donald A Director   –       •      –    2018-12-14 4 B $2.48 $148,800 D/D 60,000 200,000 2.39     -
   O'keeffe Charles B Director   –       •      –    2018-12-14 4 B $2.50 $50,000 D/D 20,000 543,376 2.39     -
   Denkhaus Donald A Director   –       •      –    2018-06-08 4 B $3.41 $68,200 D/D 20,000 140,000 2.39     -
   O'keeffe Charles B Director   –       •      –    2018-06-07 4 B $3.35 $3,352 D/D 1,000 523,376 2.31     -
   O'keeffe Charles B Director   –       •      –    2018-06-07 4 B $3.31 $13,222 D/D 4,000 522,376 2.39     -
   O'keeffe Charles B Director   –       •      –    2018-06-01 4 B $3.74 $18,680 D/D 5,000 518,376 2.39     -
   Denkhaus Donald A Director   –       •      –    2018-05-30 4 B $3.75 $75,000 D/D 20,000 120,000 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2018-04-03 4 B $2.29 $45,800 D/D 20,000 4,717,693 2.81     -
   O'keeffe Charles B Director   –       •      –    2017-11-16 4 OE $0.47 $23,500 D/D 50,000 513,376     -
   Mcenany Patrick J President and CEO   •       •      –    2017-11-13 4 OE $0.00 $0 D/D 26,667 4,697,693     -
   Tierney David S Director   –       •      –    2017-11-09 4 D $0.00 $0 D/D (7,860) 305,541     -
   Tierney David S Director   –       •      –    2017-11-09 4 OE $0.47 $23,500 D/D 50,000 313,401     -
   Coelho Philip H Director   –       •      –    2017-11-09 4 D $0.00 $0 D/D (7,860) 215,427     -
   Coelho Philip H Director   –       •      –    2017-11-09 4 OE $0.47 $23,500 D/D 50,000 223,287     -
   Grande Alicia Chief Financial Officer   •       –      –    2017-11-06 4 OE $0.47 $94,000 D/D 200,000 396,346     -
   Miller Steve Chief Operating Officer   •       –      –    2017-11-06 4 OE $0.47 $94,000 D/D 200,000 657,687     -
   Mcenany Patrick J President and CEO   •       •      –    2017-11-06 4 OE $0.47 $94,000 D/D 200,000 4,671,026     -
  312 Records found
  Previous  10  11  12  13   
  Page 10 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us